Description | ZIKV-195 is a potently human neutralizing antibody, which specifically recognizes ZIKV E protein. The potent neutralizing antibody ZIKV-195 broadly inhibits ZIKV strains and has therapeutic potential against ZIKV infection. This product has been detected by Enzyme-linked immunosorbent assay, Flow cytometry and Neutralization assay. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | ZIKV |
Cross Reactivity | African (Dakar 41525 and MR 766), Asian (H/PF/2013 and Malaysia P6740), American (Paraiba 2015) |
Epitope | ZIKV-195 binds to both E protomers forming dimers within one icosahedral asymmetric unit. |
Neutralization Mechanism | ZIKV-195 binds to both E protomers forming dimers, thereby stabilizing the E dimers on the mature ZIKV particle and possibly preventing formation of fusogenic trimers. |
IC50 | 77-600 ng/mL |
Isotype | Human IgG |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA; FC; Neut |
Application Notes | Neutralization assay (Neut): Serial dilutions of mAbs were incubated with ∼100 FFU of different ZIKV strains for 1 h at 37°C. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | ZIKV E |
Alternative Name | Zika virus envelope protein |
Research Area | Infectious Disease |
Related Disease | Severe neurological diseases |